Drug‐induced anaphylaxis in Australia: we need a national drug allergy registry

Michaela Lucas and Sandra Vale
Med J Aust 2022; 216 (10): . || doi: 10.5694/mja2.51527
Published online: 6 June 2022

A comprehensive adverse drug reaction registry with validated information would improve patient safety and care

Just over two years ago, the Victorian Department of Health introduced mandatory reporting of cases of anaphylaxis in people presenting to public and private emergency departments,1 facilitating data collection unique in Australia. In this issue of the MJA, Drewett and colleagues report their analysis of the first two years of data collected, focusing on medication‐related anaphylaxis.2 While food allergy was the leading cause of anaphylaxis, especially in younger people, drug‐related anaphylaxis accounted for 12% of all cases, and for a relatively high proportion in adults aged 40 years or more. Antimicrobial agents and non‐steroidal anti‐inflammatory drugs were most frequently involved.2

  • 1 The University of Western Australia, Perth, WA
  • 2 Australasian Society of Clinical Immunology and Allergy, Sydney, NSW
  • 3 National Allergy Strategy, Sydney, NSW
  • 4 Sir Charles Gairdner Hospital, Perth, WA
  • 5 Perth Children’s Hospital, Perth, WA

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.